Ythdf2 deficiency under IL-4 and TGF-β signaling promotes Th9 differentiation and enhances IL-9 and IL-21 secretion, thereby improving CD8+ T-cell and NK-cell infiltration and cytotoxicity, ultimately strengthening anti-tumor immunity (67). The gene discussed is CD8A; the disease is neoplasm.